您要查找的是不是：
- monitoring system of rational drug application 合理用药监测系统
- rational drug application 合理用药
- Rational drug use is the key to lower ADR. 合理用药是降低ADR发生的关键;
- Investigational New Drug Application (IND) for the compound. 为化合物的研究中的新药物申请 (IND)。
- Objective To offer reference for the rational drug use of Benzylpenicillin. 目的为临床合理使用青霉素提供参考。
- Conclusion: The pharmaceutical education to patients is an indispensable link in rational drug use. 结论：药师对患者的药学教育是合理用药不可缺少的环节。
- Objective: To review various adverse reactions of Puerarin, the data were provided for clinical rational drug use. 目的:综述葛根素的各种不良反应,为临床合理用药提供资料。
- FDA said, companies that intend to market nicotine water should submit a new drug application to the agency for review. 食品暨药物管理局说，想要在市场上贩卖菸草水的公司，应向该局提出新的药品上市申请书，以便审核。
- Objective:To investigate the characteristics of ADRs induced by Shenmai injection and to guide rational drug use. 目的:探讨参麦注射液不良反应的规律及特点,以期指导合理用药。
- OBJECTIVE To find out the regulareity of ADRs associated with ceftriaxone sodium to guide rational drug use. 目的探讨头孢哌酮所致不良反应的一般规律和特点,以帮助临床合理用药。
- OBJECTIVE:To understand the knowledge about rational drug use(RDU) in inpatients. 目的:了解住院患者对合理用药的认知情况。
- CONCLUSION:Ratio ordering method deserves to be generalization and application in drug application&taking by compute... 结论比值排序法是一种值得推广应用的药房药品计算机申领方法。
- The purpose is to contribute the ophthalmological adverse reaction data for rational drug use in hospital. 旨在加深医务人员对药物产生眼部不良反应的认识,提高临床合理用药水平,避免或减少眼部不良反应的发生。
- Objective: To study the macrolide antibiotic adverse reaction and safety of drug application. 目的:探讨大环内酯类抗生素的不良反应及用药安全性。
- Conclusion Atten-tion should be paid to ADR of gatifloxacin to ensure safe and rational drug use. 结论重视加替沙星的不良反应,提倡合理用药。
- Regulatory Submissions in Electronic Format; New Drug Applications. 以电子格式递交申请:新药申请。
- In the rational drug molecular design, it can be used to distinguish the molecular conformation of ligand and its acceptor. 重点介绍了分子力学计算方法中的系统搜索、机搜索方法和分子动力学计算方法中的模拟淬火、拟退火等新技术,为药物分子设计中受体与配体分子构象的识别提供了合理可行的方法。
- Clinical trials conducted between regulatory submission of an NDA (New Drug Application) and approval of a regulatory dossier for marketing authorization. 旨在向药审机构递交了新药注册申请之后到申请药物被批准上市之前的一段时间内进行的相关药物临床试验.
- Defined daily dose (DDD) and drug utilization index (DUI) for sedative-hypnotics were calculated as an indication of rational drug use. 用限定日剂量（DDD）和药物利用指数（DUI）为指标，分析其使用情况。
- Formulation Researcher：1.Ph D. or master in formulation;2.Fluent in preformulation study;3.Persons of drug application e...... ... 公司名称：永信药品工业（昆山）有限公司工作地点：江苏省苏州市昆山市发布时间：2009-7-25
